Policy | March 19, 2025
Anupriya Patel inaugurates India Innovation Summit – Pioneering Solutions to End TB
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 m
Announces Rs. 317 crore investment in new recycling plant
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
The FDA determined that the data presented in a 2022 color additive petition show that this ingredient causes cancer in male laboratory rats exposed to high levels of FD&C Red No. 3 because of a hormonal mechanism that occurs in male rats
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Pfizer's decision is based on the totality of clinical data
Subscribe To Our Newsletter & Stay Updated
